Facet Biotech Corp
SEC CIK 1441848 · FACT · last insider filing 2010-04-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lyons Gary A | Director | filed 2008 - 2010 |
| Emster Kurt VON | Director | filed 2009 - 2010 |
| Goodwin Bradford S | Director | filed 2008 - 2010 |
| Hasnain Faheem | Director · President & CEO | filed 2008 - 2010 |
| Huh Hoyoung | Director | filed 2009 - 2010 |
| Parkinson David Ross | Director | filed 2008 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cross Herb | VP of Finance/Prin Acctg Off | filed 2008 - 2010 |
| Guggenhime Andrew | SVP & CFO | filed 2008 - 2010 |
| Sarena Francis Willard | VP, Gen Counsel & Secy | filed 2008 - 2010 |
| Hora Maninder | VP, Product and Quality Ops | filed 2008 - 2010 |
| Llana Ted | SVP, Commercial and Corp Dev | filed 2009 - 2010 |
| Rolfe Mark | Sr. Vice Pres. and CSO | filed 2009 - 2010 |
| Mccamish Mark Anthony | Sr. VP & Chief Medical Officer | filed 2008 - 2009 |
| Shah Jaisim | SVP, Chief Business Officer | filed 2008 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.